Webinar
ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization

- Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity.
- Customizing the downstream process to address the different needs from supercoil plasmid and linear isoform.
- A platform approach with integrated processes and analytical toolboxes to accelerate plasmid development to manufacturing.